Clinical Trials Browser

Phase 2 × GSK 1363089 × Gastrointestinal × Clear all

NCT00725712 2017-08-24

Study of GSK1363089 in Metastatic Gastric Cancer

Phase 2 Completed

74 enrolled 22 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms